Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.
KEY PRODUCTS
KEY EXCIPIENTS
Reset all filters
01 1Pfanstiehl
Reset all filters
01 1A, A-TREHALOSE DIHYDRATE, HIGH PURITY, LOW ENDOTOXIN, LOW METALS, NF, EP, BP, JP, CHP (T-104-4)
Reset all filters
01 1U.S.A
Reset all filters
01 1Active
Reset all filters
01 1Blank
Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 24122
Submission : 2010-08-30
Status : Active
Type : IV
20
Pfanstiehl Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
They are recognized for Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.
One of their notable products is A, A-TREHALOSE DIHYDRATE, HIGH PURITY, LOW ENDOTOXIN, LOW METALS, NF, EP, BP, JP, CHP (T-104-4), with a corresponding US DMF Number 24122.
Remarkably, this DMF maintains an Active status since its submission on August 30, 2010, highlighting commitment to regulatory compliance.